Post-COVID Shifts in Clinical Research in the United States
Post-COVID Shifts in Clinical Research in the United States Transformations in U.S. Clinical Research After COVID-19: Regulatory and Operational Shifts Introduction The COVID-19 pandemic profoundly disrupted clinical research in the United States, forcing regulators, sponsors, and sites to adapt rapidly. Lockdowns, site closures, and patient hesitancy led to unprecedented delays and trial suspensions. In response,…
Read More “Post-COVID Shifts in Clinical Research in the United States” »